Effort intolerance, measured objectively by reduced peak oxygen consumption (Vo 2 ), has been considered as an important prognosticator in degenerative mitral regurgitation (MR). However, its mechanism is unknown.
D
egenerative mitral regurgitation (MR) occurs in about 10% of subjects with age ≥75 years old 1 and, when severe, is associated with increased mortality. 2 Current guideline indications for mitral valve surgery includes symptomatic or asymptomatic with abnormal left ventricular (LV) systolic function, newonset atrial fibrillation, or resting pulmonary hypertension (PH). 3 However, approximately half of patients with severe MR is unoperated because of their advanced age and comorbidities. 4 To optimally treat these patients, more detailed perioperative risk assessment of mitral valve surgery may be crucial for the clinicians.
Stressing the cardiopulmonary circulation using exercise can reveal exercise-induced MR and PH, 5, 6 facilitate early detection of pulmonary vascular disease, 7, 8 and unmask a deterioration in right ventricular (RV) function and RV-to-pulmonary artery (PA) uncoupling 9 ; all of these factors may have important clinical implications. In left-sided heart failure, a sustained backward transmission of increased LV filling pressure is the main cause of PA remodeling and RV pressure overload. 10 Moreover, effort intolerance, measured objectively by reduced peak oxygen consumption (Vo 2 ) using cardiopulmonary exercise test (CPET), is the primary chronic symptom and has been considered as a noteworthy prognostic factor in severe degenerative MR. 11, 12 However, its mechanism is not well defined.
Exercise-stress echocardiography (ESE) is a wellknown, noninvasive, and clinically useful method to assess hemodynamic response during exercise even in patients with valvular heart disease; yet, available data for its accuracy are scant. 13 Subsequently, the latest guidelines give no priority to ESE to determine indication for mitral valve surgery in degenerative MR. 3 The objectives of this study were (1) to determine the accuracy of echocardiographic estimation of PA pressures and cardiac output (CO) during exercise in comparison with simultaneous invasive hemodynamic monitoring by right heart catheterization and (2) to investigate the factors associated with effort intolerance in patients with degenerative MR using a combined ESE-CPET protocol, focusing on several exercise-induced hemodynamic responses.
METHODS Population
The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure. We prospectively examined 35 eligible patients with grade III+ or greater chronic degenerative MR referred for functional assessment in this study at Hiroshima University Hospital between April 2016 and October 2017. Exclusion criteria were discontinuance of exercise before reaching anaerobic threshold (AT) because of lower limb weakness or inadequate image at rest or during exercise. The assessable tricuspid regurgitation (TR) spectral Doppler envelopes were determined using 2 predefined criteria: (1) extension of the signal for at least half of systole, and (2) well-defined border.
14 The pathophysiology of MR was divided into 2 groups: fibroelastic deficiency and Barlow disease. Fibroelastic deficiency was defined as thin excess tissue limited to a prolapsing segment of a mitral leaflet, whereas Barlow disease was defined as multisegment leaflet prolapse with diffuse thickening and excessive tissue. 15 Study group
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consisted of minimally symptomatic patients in the grade III+ range (effective regurgitant orifice area, 0.30-0.39 cm 2 ) 16 or asymptomatic severe MR. Analysis was performed in the MR group, comparing the 14 patients who had reduced exercise capacity (<70% of predicted peak Vo 2 ) with the 11 patients who had preserved exercise capacity (≥70% of predicted). All patients signed the informed consent forms which were approved by the local ethics committee.
Invasive Hemodynamic Monitoring
A 4F Balloon Wedge-Pressure Catheter (Teleflex, Wayne, PA) was advanced to the PA with fluoroscopic guidance. A 4F sheath was also inserted into the right radial artery. The pressure transducer was positioned using as reference 5 cm below the axillary fold. At rest, end-expiratory systemic arterial, PA, and pulmonary arterial wedge pressure were measured using a hemodynamic monitoring system (IntelliVue MP70; Philips, Andover, MA) calibrated before each study. During exercise, these pressures were measured continuously and averaged over 3 beats. Blood samples were obtained at 4 predefined levels (rest, unloaded cycling, AT, and peak) through the catheters inserted to measure arterial and mixed vein O 2 contents. In addition, CO was measured using true Fick method with direct measurement of Vo 2 and A−Vo 2 difference.
Cardiopulmonary Exercise Test
A symptom-limited graded ramp bicycle exercise test was performed in a semisupine position at 30° lateral decubitus in a dedicated ergometer (Echo Stress Table 750EC ; Lode, Groningen, the Netherlands). Patients pedaled at a constant cadence (50 rotations/min), starting with 3 minutes of unloaded cycling, which was then increased using a 10 W/ min ramp protocol. 17 During the test, the 12-lead ECG and heart rate (HR) were continuously monitored. Breath-bybreath minute ventilation, CO 2 production (Vco 2 ), and Vo 2 were measured using a commercially available metabolic cart (MINATO 280S; Minato Ikagaku, Osaka, Japan). Peak Vo 2 was the highest averaged 30-s Vo 2 during exercise. AT was determined manually using the modified V-slope method. The respiratory exchange ratio was defined as the ratio between Vco 2 and Vo 2 obtained from ventilatory expired gas analysis.
Echocardiographic Assessment
Comprehensive resting and exercise transthoracic echocardiography was performed by experienced cardiologists (Drs Utsunomiya and Hidaka) blinded to invasive hemodynamic data using a Vivid 9 ultrasound system (GE Vingmed, Horten, Norway). All measurements and recordings were performed according to the American Society of Echocardiography recommendations. 18 At rest, LV volumes, left atrial volume, and LV ejection fraction were calculated with the modified Simpson method using apical 2-and 4-chamber views and indexed to body surface area. Severity of MR was determined using vena contracta (VC) width. 16 Averaged VC width from apical 2-and 4-chamber views was calculated to account for its noncircular and ellipsoidal shape. Stroke volume was calculated by multiplying the LV outflow tract area by the LV outflow tract velocity-time integral measured by pulsed-wave Doppler. CO was obtained by stroke volume×HR. Systolic PA pressure (SPAP) was measured according to guidelines by using the following formula: 4×(peak TR velocity [m/s]) 2 +right atrial pressure (mm Hg). Right atrial pressure was estimated from the inferior vena cava diameter and respiratory changes. 19 Mean PA pressure (MPAP) was calculated using the formula: 0.6×systolic PA pressure+2, as proposed by Chemla et al. 20 Tricuspid annular plane systolic excursion (TAPSE) was measured as the distance of systolic movement of the junction between the tricuspid valve and the RV free wall using 2-dimensional images and anatomic M-mode. 19 During exercise, (1) color Doppler images in apical 2-and 4-chamber views, (2) pulsed-wave Doppler in the LV outflow tract, (3) continuous wave Doppler of TR, (4) inferior vena cava diameter and collapsibility, and (5) TAPSE were acquired at the end of each levels (unloaded cycling, AT, and peak). Peak exercise images were defined as those captured immediately after reaching respiratory exchange ratio >1.05. 21 Measurements were averaged over 3 beats (sinus rhythm, n=22) or over 5 beats (atrial fibrillation, n=3).
Exercise-Induced Hemodynamic Responses
We have paid particular attention to several hemodynamic responses to exercise that may signal a worsening outcome as follows: SPAP at peak exercise (exercise-induced PH), 5 ΔMR VC calculated as exercise-induced change in MR, 6 the slope of MPAP versus CO, and the slope of TAPSE versus SPAP (Figure 1 ). Increasing MPAP/CO slope may be correlated with abnormal pulmonary vascular reserve, 8, 14, 22 RV-to-PA uncoupling, 9 or both. Meanwhile, the TAPSE/SPAP slope has been considered as an index of RV contractile reserve by plotting the relationship between TAPSE as a measure of length and SPAP as a measure of developed force. 23 HR reserve was calculated by the following: 100×(peak HR-baseline HR)/baseline HR (%). Chronotropic incompetence on exercise testing was determined when <62% of HR reserve was used.
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Statistical Analysis
Continuous variables are expressed as median (25th and 75th percentiles) or mean±SD. Group comparisons were performed by nonparametric Wilcoxon rank-sum tests. For categorical variables, the χ 2 test or Fisher exact test was used, as appropriate. Correlations between echocardiographic and invasive hemodynamics were assessed using Pearson correlation coefficient and linear regression and concordance correlation coefficient. The accuracy of echocardiography-derived hemodynamics was tested using Bland-Altman analysis as compared to simultaneously obtained invasive measurements. Coefficient of variation was defined as the SD of the difference divided by the mean value of between catheterization and echocardiography. A 2-way ANOVA for repeated measures with Mauchly test for sphericity assumptions, followed by a Tukey posthoc test, was used to evaluate the effects of time and group (patients with preserved and reduced exercise capacity) interaction on SPAP, MPAP, CO, stroke volume, HR, systemic arterial pressure, MR VC, TAPSE, MPAP/CO slope, and TAPSE/SPAP slope. To identify factors related to peak Vo 2 , univariable, and multivariable linear regression analyses were performed. The following potential univariable predictors were considered for the analysis: HR reserve, MPAP/CO slope, and TAPSE/SPAP slope. Because of multicollinearity, only HR reserve (not peak CO), MPAP/CO slope (not baseline and peak MPAP), and TAPSE/SPAP slope (not peak TAPSE) were entered into the model. Owing to small number of study population (n=25), multivariable analyses could only adjust for 2 potential confounding variables at a time, adjustment for age and LV ejection fraction (model 1); MR effective regurgitant orifice area and SPAP at baseline (model 2); and ΔMR VC and SPAP at peak exercise (model 3). Receiver-operating characteristic curves were generated to determine the diagnostic accuracy of SPAP at peak exercise, HR reserve, MPAP/CO slope, and TAPSE/SPAP slope to detect a reduced exercise capacity (<70% of predicted peak Vo 2 ). Reproducibility of echocardiographic measurements, as described by absolute differences with SDs and intraclass correlations, was evaluated in 10 datasets a month after the initial measurement by first author for intraobserver variability and by a second observer for interobserver variability. A 2-tailed P<0.05 was considered as statistical significance. SPSS Statistics 21.0 (IBM, Chicago, IL) was used for statistical analyses.
RESULTS
Of 35 patients enrolled as having asymptomatic/minimally symptomatic grade III+ or greater degenerative MR, 5 patients were excluded because of discontinuance of exercise before reaching AT because of lower limb weakness, 4 were not being assessed or not detectable TR spectral Doppler envelopes at rest, and 1 was poor image quality. A Doppler echocardiographic estimate of SPAP could be obtained in 31 (89%) patients at rest. The number of patients in whom echocardiographic measures of SPAP were possible decreased to 30 (86%), 23 (66%), and 22 (63%) for unloaded cycling, AT, and peak exercise, respectively. After excluding patients according to our criteria, 25 (71%) patients remained and were included in the study.
Patient Characteristics
The baseline characteristics of the patients are summarized in Table 1 . Median age of patients included was 64 years, and 56% were male. New York Heart Association functional class II symptoms were present in 15 (60%) patients. Only 3 (12%) patients were in atrial fibrillation at the time of testing. Abnormal LV systolic function consisted of reduced ejection fraction of ≤60% in 7 (28%) and increased end-systolic dimension of ≥40 mm in 6 (24%) patients. Preexisting PH of SPAP >50 mm Hg was seen in 2 (8%) patients. As for CPET variables, all patients reached a peak exercise respiratory exchange ratio >1.05. The median peak Vo 2 was 15.3 mL/min per kilogram (63% predicted). The primary limit to testing was attributed to a cardiac cause in all study popula- (4) tricuspid annular plane systolic excursion (TAPSE) were acquired at the end of each level. Systolic pulmonary artery pressure (SPAP) at peak exercise and mitral regurgitation vena contracta (ΔMR VC) were measured to assess exercise-induced pulmonary hypertension and MR. The slope of mean pulmonary artery pressure (MPAP) vs cardiac output (CO) and the slope of TAPSE vs SPAP were also calculated as an index of abnormal pulmonary vascular reserve and impaired right ventricular contractile reserve, respectively. SAP indicates systemic arterial pressure; TRV, peak TR velocity; Vo 2 , oxygen consumption; and VTI, velocity-time integral.
tion, demonstrating intolerable dyspnea (n=23, 92%) or severe fatigue (n=2, 8%) at the end of peak exercise.
Agreement of PA Pressures and CO by Echocardiography Versus Invasive Measures
Overall, as shown in Figure I in the Data Supplement, an excellent agreement was found between echocardiographic and invasive measures for SPAP (r=0.91; P<0.001; bias, −0.8±8.2 mm Hg), MPAP (r=0.87; P<0.001; bias, 1.0±7.4 mm Hg), and CO (r=0.88; P<0.001; bias, 0.35±1.8 L/min). With regard to PA pressures at rest, no significant bias was observed for echocardiographic estimation relative to invasive SPAP ( Figure 2A ; Table 2 ). Meanwhile, there was only minimal bias between echocardiographyderived MPAP calculated using the Chemla formula and invasively measured MPAP (−1.5±4.1 mm Hg; P=0.022) with 95% limits of agreement of −9.5 to 6.5 mm Hg (Figure 2A) . At peak exercise, echocardiography-based SPAP and MPAP correlated well with invasive measures. There was no significant bias between invasive and noninvasive measures of SPAP and MPAP ( Figure 2B ; Table 2 ). On the other hand, CO calculated by echocardiography was slightly underestimated values using catheterization at rest (bias, 0.4±1.8 L/min; P=0.014), but the differences in CO did not reach statistical significance at peak exercise ( Figure 2B ; Table 2 ).
Agreement of MPAP/CO and TAPSE/ SPAP Slopes by Echocardiography Versus Invasive Measures
Multipoint MPAP/CO and TAPSE/SPAP slopes could be determined by echocardiography in 24 (96%) patients. As depicted in Figure 3 , an excellent correlation and agreement were found between noninvasively and invasively measured MPAP/CO slopes, with slightly underestimating the values by echocardiography (r=0.92; P<0.001; bias, 0.98±3.0 mm Hg/L per minute; Table 2 ). As for TAPSE/SPAP slope, echocardiography-based TAPSE/SPAP slopes correlated well with invasive measures. There was no significant bias between invasive and noninvasive measures of TAPSE/SPAP slopes ( Figure 3 ; Table 2 ).
Echocardiographic and Stress Correlates of Exercise Capacity
Various clinical and echocardiographic characteristics stratified by exercise capacity are given in Table 3 . Echocardiographic parameters and exercise-induced hemodynamic responses of the MR subgroups in each of the exercise phases are shown in Figure 4 . Patients with reduced exercise capacity had a higher SPAP and MPAP both at rest and at peak exercise ( Figure 4A and 4B, all P<0.02). SPAP and MPAP increased during exercise in both MR subgroups. However, in patients with preserved exercise capacity, it increased mainly up to AT and then showed minor changes between AT and peak exercise, whereas in patients with reduced exercise capacity it started higher, increased steadily throughout exercise and then showed major change between AT and peak exercise (P<0.05 for the time-group interaction). However, there was no statistical difference in systemic arterial pressure between the groups ( Figure 4F ). Patients with reduced exercise capacity had attenuated changes in CO (P=0.02 for the time-group interaction; Figure 4C ), HR (P=0.002 for the time-group interaction, Figure 4E ), and TAPSE (P<0.001 for the time-group interaction, Figure 4H ), resulting in steeper MPAP/CO and Values are median (25th and 75th percentiles) or number (%). ACE indicates angiotensin-converting enzyme; ARB, angiotensin receptor blocker; A−Vo 2 difference, arterial-venous difference; CO, cardiac output; ERO, effective regurgitant orifice, LA, left atrial; LV, left ventricular; MR, mitral regurgitation; NT-proBNP, N-terminal pro-B-type natriuretic peptide; NYHA, New York Heart Association; SPAP, systolic pulmonary artery pressure; TAPSE, tricuspid annular plane systolic excursion; VC, vena contracta; Vco 2 , carbon dioxide production; VE, minute ventilation; and Vo 2 , oxygen consumption.
gentler TAPSE/SPAP slopes compared with those with preserved exercise capacity (Figures 4I and 4J ; Table 3 ). In contrast, patients with reduced exercise capacity had a lower stroke volume at rest (P=0.034) and at peak exercise (P=0.005) as compared to those with preserved exercise capacity; however, there was no significant difference in stroke volume reserve between the groups ( Figure 4D ; Table 3 ). To explore the contribution of demographic, clinical, and echocardiographic parameters on maximal exercise capacity, univariate linear regression analyses were performed. Age, LV ejection fraction, SPAP and MPAP at rest, and several exerciseinduced hemodynamic responses, including SPAP, MPAP, CO, and TAPSE at peak exercise, HR reserve, ΔMR VC, MPAP/CO slope, and TAPSE/SPAP slope, showed significant correlation with peak Vo 2 ( Table 3) .
Predicting Effort Intolerance With ESE
HR reserve, MPAP/CO slope, and TAPSE/SPAP slope were separately entered into multivariable linear regression analyses (Table 4 ). All 3 variables were significantly associated with peak Vo 2 even after being adjusted for age and LV ejection fraction (model 1), MR effective regurgitant orifice area and SPAP at baseline (model 2), and ΔMR VC and SPAP at peak exercise (model 3), indicating that chronotropic incompetence, abnormal pulmonary vascular reserve, and impaired RV contractile reserve are of importance for explaining effort intolerance in patients with degenerative MR. Because patients with the use of β-blockers (n=8) tended to have a lower HR reserve compared with those with no β-blockers usage (55±32 % versus 83±43 %; P=0.08), we performed further adjustment for use of β-blockers, but the results did not change.
Presence of an effort intolerance during exercise was defined as a CPET-derived measured predicted peak Vo 2 <70%. Using a receiver-operating characteristics analysis, the MPAP/CO slope of 4.13 mm Hg/L per minute from rest to peak exercise had a sensitivity and a specificity for predicting effort intolerance of 57% (95% CI, 31%-83%) and 91% (95% CI, 74%-100%), respectively, whereas the TAPSE/SPAP slope of 0.25 mm/ mm Hg had a respective sensitivity and specificity of 86% (95% CI, 67%-100%) and 82% (95% CI, 59%-100%; Figure 5 ).
Reproducibility
The intraobserver and interobserver variability of echocardiographic measurements were SPAP, 2.5±1.9 and 3.3±2.6 mm Hg; CO, 0.15±0.14 and 0. 
DISCUSSION
This study is the first to validate the accuracy of echocardiography-derived PA pressures and CO at rest and during exercise in asymptomatic/minimally symptomatic patients with grade III+ or greater degenerative MR by simultaneously performed right heart catheterization and echocardiography. Furthermore, determination of echocardiography-derived MPAP/CO and TAPSE/SPAP slopes by multipoint method was feasible in the great majority of subjects and can provide a sufficiently robust estimate of pulmonary vascular reserve and RV contractile reserve with high accuracy for identifying low peak Vo 2 . Finally, we demonstrated that in patients with grade III+ or greater degenerative MR undergoing semisupine exercise testing with ESE-CPET, chronotropic incompetence, abnormal pulmonary vascular reserve, and limited RV contractile reserve were independently associated with lower exercise capacity even after adjustment for exercise-induced MR or PH, providing new insights into the mechanisms of effort intolerance with pathophysiologic and clinical implication.
Accuracy of Echocardiography to Estimate PA Pressures and CO With Exercise
Resting SPAP and MPAP can be estimated by Doppler echocardiography, and its correlation coefficient of echocardiography and catheterization was high. 20, 24 However, data on the feasibility and robustness of ESE to accurately estimate PA pressures and CO are limited. To date, only 3 previous studies have investigated the accuracy of ESE compared with right heart catheterization during exercise.
14,22, 25 Kovacs et al 25 analyzed the SPAP values obtained by semisupine ESE and catheterization in 28 patients with connective tissue disease and found that the bias and the SD of the bias were relatively wide at peak exercise (−5.6±19.0 mm Hg). Claessen et al 22 performed semisupine ESE and catheterization within 24 hours in 61 subjects with various cardiopulmonary condition, including healthy nonathletes. They showed that the feasibility of echocardiographic estimation of PA pressures was 69% (42/61) at peak exercise and that the available measures obtained during exercise can provide a sufficiently robust estimate of PA pressures and CO (SPAP, 2.9±13.6 mm Hg; MPAP, 7.3±7.4 mm Hg; and CO, −4.2±4.0 L/min). However, the assessments in these studies were not performed simultaneously.
Most recently, van Riel et al 14 simultaneously assessed PA pressures at rest and with exercise in 65 patients with unexplained exertional intolerance by right heart catheterization and upright ESE. Notably, the prevalence of patients with excellent TR quality represented only 68% at rest and 34% with exercise. Although echocardiographic PA pressure assessment demonstrated good correlation with invasive measures during upright exercise, its accuracy was highly dependent on the quality of the TR spectral Doppler envelope.
14 In the present study, we showed a relatively high feasibility (63%) and accuracy of estimated PA pressures at peak exercise. The patient position during exercise (upright versus semisupine) may also be responsible for the feasibility. Although echocardiography consistently overestimated MPAP and underestimated CO at rest as compared to the catheterization-derived values in the present study, its bias was small, and the SD of the bias was acceptable range. Importantly, this resulted in consistent lower MPAP/CO slopes obtained with echocardiography than those obtained with catheterization (Table 2) . Nevertheless, the echocardiography-derived MPAP/CO slope predicted effort intolerance in the present study.
Mechanisms of Effort Intolerance in Degenerative MR
Effort intolerance is the primary manifestation and prognosticator in patients with degenerative MR even Correlation coefficients with 95% CIs (upper) and Bland-Altman plots (lower) of the mean pulmonary artery pressure (MPAP)/cardiac output (CO) and peak tricuspid regurgitation velocity (TAPSE)/systolic pulmonary artery pressure (SPAP) slopes were depicted according to the predicted peak Vo 2 ≥70% or <70%. ρ c denotes concordance correlation coefficient. CV indicates coefficient of variation; and Vo 2 , oxygen consumption.
Utsunomiya et al; Mechanisms of Effort Intolerance when patients are stable and compensated 11, 12 ; however, its pathophysiology is not well understood. Our study suggests contribution of central factors, such as chronotropic incompetence and pulmonary vascular and RV contractile reserve abnormalities to effort intolerance. Laufer-Perl et al investigated 20 patients with rheumatic mitral stenosis using a combined ESE-CPET protocol that peripheral factors, presumed skeletal muscle abnormalities, and ventilatory abnormalities were associated with effort intolerance probably because of systemic inflammation and increased levels of inflammatory cytokines. 21 However, in the present study, Values are median (25th and 75th percentiles) or number (%). ACE indicates angiotensin-converting enzyme; ARB, angiotensin receptor blocker; A−Vo 2 difference, arterial-venous difference; CO, cardiac output; ERO, effective regurgitant orifice, HR, heart rate; LA, left atrial; LV, left ventricular; MPAP, mean pulmonary artery pressure; MR, mitral regurgitation; NA, not assessed; NYHA, New York Heart Association; SPAP, systolic pulmonary artery pressure; TAPSE, tricuspid annular plane systolic excursion; VC, vena contracta; VE, minute ventilation; and Vo 2 , oxygen consumption.
A−Vo 2 difference at peak exercise was not determinant of reduced peak Vo 2 in patients with degenerative MR.
Degenerative MR may be dynamic and marked changes in MR severity were associated with exercise-induced PH and reduced symptom-free survival. 6 In this study, baseline or exercise MR severity was not an independent predictor of effort intolerance. In addition, univariate analysis revealed the association of changes in MR VC and peak Vo 2 ; however, this relationship was no longer significant after multivariable adjustment. The lack of association between MR severity and exercise performance also raises questions as to whether fixing the MR will improve exercise capacity in these patients. That would be an important question to assess in future studies with follow-up ESE-CPET after mitral valve repair is performed.
Importantly, chronotropic incompetence was more seen in patients with MR and reduced exercise capacity (57% versus 18%, P=0.048), and HR reserve was a strong independent predictor of peak Vo 2 regardless of β-blocker therapy. This phenomenon has also been demonstrated in patients with heart failure with preserved ejection fraction 26 and reduced ejection fraction. 27 In this functional assessment using CPET, we found that all patients reached a peak exercise respiratory exchange ratio >1.05. Thus, chronotropic incompetence does not merely reflect the consequences of reduced motivation but seems to play an independent role in the pathogenesis of reduced exercise capacity in patients with degenerative MR.
PH leads to increased morbidity across the cardiopulmonary disease spectrum. Noninvasive studies have suggested in asymptomatic degenerative MR that exercise-induced PH, defined as a peak SPAP >60 mm Hg, was independently associated with reduced symptomfree survival. 5, 6 Notably, PH begets PH because perivascular inflammation and occlusive neointimal arteriopathy are driven by hemodynamic stress itself. 28 A large cohort study was followed and confirmed a continuum of mortality and hospitalization risk according to MPAP level. 29 Furthermore, pulmonary circulation pressure- Rest, unloaded cycling, anaerobic threshold (AT), and peak during a combined exercise-stress echocardiography-cardiopulmonary exercise test protocol for (A) systolic pulmonary artery pressure (SPAP), (B) mean pulmonary artery pressure (MPAP), (C) cardiac output (CO), (D) stroke volume, (E) heart rate (HR), (F) systemic arterial pressure (SAP), (G) MR vena contracta (VC), and (H) peak tricuspid regurgitation velocity (TAPSE) in patients with degenerative MR and preserved exercise capacity (green) and patients with MR and reduced exercise capacity (pink). I, relationship of MPAP and CO in the 2 groups. J, relationship of TAPSE and SPAP.
flow relationships during exercise have the potential to assess pulmonary vascular reserve and predict exercise capacity and future development of PH. 7, 8, 30 We found that MPAP/CO slopes obtained with echocardiography predicted effort intolerance in asymptomatic/minimally symptomatic patients with degenerative MR even after adjustment for ΔMR VC and SPAP at peak exercise (Table 4 , multivariable model 3). When PA pressures are elevated during exercise, RV contractility typically augments against afterload increase. Thus far, there are few data assessing changes in RV function during exercise. Isolated SPAP analysis is flawed in patients who have the right ventricle working in the plateau portion of the Frank-Starling curve and being still able to develop some pressure despite no improvement in the functional response. Guazzi et al 23 reported that the relationship of TAPSE to SPAP, an index of in vivo RV length-force relationship, provides a noninvasive assay of RV contractile performance and can predict prognosis in heart failure patients. Borlaug et al 31 recently demonstrated impaired RV reserve in patients with preserved ejection fraction and its association with high filling pressures and inadequate CO responses during exercise. We adopted the relationship between TAPSE and SPAP at rest versus peak exercise, that is TAPSE/ SPAP slopes, as a tool to assess RV contractile reserve to incremental exercise, demonstrating its ability to predict effort intolerance by multivariable analysis. These findings may highlight the importance of biventricular dysfunction in degenerative MR, suggesting that novel therapies targeting myocardial reserve in both the LV and RV may be effective to improve exercise capacity.
Clinical Implication
Mitral valve surgery for severe degenerative MR is currently recommended by a class I indication in both European Society of Cardiology and American College of Cardiology and American Heart Association guidelines when certain exertional dyspnea occur, or LV function is impaired in asymptomatic patients. Previous study had demonstrated that exertional dyspnea commonly occurs well before LV dysfunction or dilatation. 32 However, the management of patients with severe degenerative MR is still challenging in daily clinical practice, particularly when their exertional dyspnea is ambiguous and hard to be determined. Namely, it would be difficult for the clinicians to determine New York Heart Association functional class clearly in such patients with asymptomatic or minimally symptomatic severe degenerative MR. The strength of the present study is elucidating pathophysiology associated with impaired exercise performance in these patients. In American College of Cardiology/American Heart Association guideline, symptoms in stage D include not only exertional dyspnea but also effort intolerance; 3 therefore, assessing CO indicates cardiac output; ERO, effective regurgitant orifice; HR, heart rate; LV, left ventricular; MPAP, mean pulmonary artery pressure; MR, mitral regurgitation; SPAP, systolic pulmonary artery pressure; TAPSE, tricuspid annular plane systolic excursion; VC, vena contracta; and Vo 2 , oxygen consumption.
*Owing to small number of study population (n=25), multivariable analyses could only adjust for 2 potential confounding variables at a time, adjustment for age and LV ejection fraction (model 1); MR ERO area and SPAP at baseline (model 2); and ΔMR VC and SPAP at peak exercise (model 3).
†For each 1 SD change in the independent variable. Figure 5 . Diagnostic accuracy of exercisestress echocardiography to assess effort intolerance in patients with degenerative mitral regurgitation. Receiver-operating characteristic curves for systolic pulmonary artery pressure (SPAP) at peak exercise, heart rate (HR) reserve, and echocardiographic mean pulmonary artery pressure (MPAP)/cardiac output and peak tricuspid regurgitation velocity/SPAP relationships. AUC indicates area under the curve.
effort intolerance, measured objectively by reduced peak oxygen consumption using CPET, would be vital to determination of optimal timing of mitral valve surgery in asymptomatic/minimally symptomatic cases.
Limitations
First, this is a single-center study. Owing to small number of study population, the strength of the imaging variables to add incrementally to the prediction of effort intolerance is uncertain. Further validation in a larger multicenter study requires to confirm our findings. Second, the study population was mixed (symptomatic and asymptomatic), and some had other indications for surgery, such as LV dysfunction and dilatation. Furthermore, outcome assessment was not performed. Therefore, the clinical and prognostic utility of exercise-stress tests using a combined ESE-CPET protocol for potentially altering clinical management decisions remains unclear. Third, 4 patients with not being assessed or not detectable TR spectral Doppler envelope at rest were excluded from this study because of its confounding effect on the measurements of PA pressures. 14 Thus, our results cannot be extrapolated to such cases. Fourth, MPAP was calculated using the Chemla formula in the present study. Other methods, such as TR mean pressure gradient+right atrial pressure, may produce different results. Another limitation is the lack of control subjects with no or mild MR. Still, we could reach several conclusions mainly focusing on mechanisms of effort intolerance in degenerative MR.
Conclusions
The agreement between echocardiographic and invasive measures of PA pressures and CO during semisupine exercise is acceptable for using ESE in clinical practice in asymptomatic/minimally symptomatic patients with degenerative MR. In those patients, effort intolerance is predominantly the result of chronotropic incompetence, abnormal pulmonary vascular reserve, and limited RV contractile reserve and not simply because of exercise-induced MR or PH.
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